Date of response: 24 July 2026

Outcome: Information partially disclosed

Category: Medicines Optimisation

Request

Informed consent protocols and patient leaflet policies for Medroxyprogesterone Acetate (Depo-Provera)

ICB Response

NN ICB 26 1680 Response Letter Final

pdf (215K)

Close
Search